Common Equity: The sum of all common equity items.
Eli Lilly and Company (LLY) had Common Equity of $23.85B for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$17.60B |
|
$5.58B |
|
$3.01B |
|
$14.59B |
|
$10.24B |
|
$7.37B |
|
$-133.10M |
|
$7.23B |
|
$7.23B |
|
$5.58B |
|
$5.58B |
|
$5.58B |
|
$5.58B |
|
$7.37B |
|
$7.84B |
|
896.90M |
|
898.80M |
|
$6.22 |
|
$6.21 |
|
| Balance Sheet Financials | |
$62.07B |
|
$22.32B |
|
$52.86B |
|
$114.94B |
|
$40.14B |
|
$40.87B |
|
$50.94B |
|
$91.08B |
|
|
Common Equity |
$23.85B |
$11.51B |
|
$23.85B |
|
946.21M |
|
| Cash Flow Statement Financials | |
$13.59B |
|
$-8.17B |
|
$665.80M |
|
$3.27B |
|
$9.79B |
|
$6.52B |
|
$489.90M |
|
$-4.04B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.55 |
|
-- |
|
-- |
|
0.63 |
|
1.78 |
|
82.91% |
|
41.85% |
|
41.85% |
|
-- |
|
41.09% |
|
31.72% |
|
$8.29B |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.25 |
|
0.90 |
|
99.49 |
|
23.41% |
|
48.52% |
|
4.86% |
|
8.62% |
|
$25.21 |
|
$9.23 |
|
$15.12 |
|